Toxoplasma gondii microneme protein 6 (MIC6) is a potential vaccine candidate against toxoplasmosis in mice

Vaccine

Volumn 27, Issue 47, 2009, Pages 6570-6574

  Peng, Gao Hui ^a   Yuan, Zi Guo ^a   Zhou, Dong Hui ^a   He, Xian Hui ^a   Liu, Miao Miao ^a   Yan, Chao ^a   Yin, Chuang Cheng ^a   He, Yong ^a   Lin, Rui Qing ^a   Zhu, Xing Quan ^a  

^a SOUTH CHINA AGRICULTURAL UNIVERSITY   (China)

Author keywords

Immunity; Microneme protein 6; Toxoplasma gondii; Toxoplasmosis; Vaccine

Indexed keywords

DNA VACCINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; MICRONEME PROTEIN 6; PHOSPHATE BUFFERED SALINE; TOXOPLASMA GONDII VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA IMMUNIZATION; FEMALE; GENE SEGREGATION; IMMUNE RESPONSE; KUNMING MICE; LYMPHOCYTE PROLIFERATION; MOUSE; MOUSE STRAIN; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITE IMMUNITY; PLASMID; PRIORITY JOURNAL; SURVIVAL; TH1 CELL; TOXOPLASMA GONDII; TOXOPLASMOSIS;

ANIMALS; ANTIBODIES, PROTOZOAN; CELL ADHESION MOLECULES; CELL PROLIFERATION; CYTOKINES; FEMALE; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; IMMUNOGLOBULIN G; LYMPHOCYTE ACTIVATION; MICE; PLASMIDS; PROTOZOAN PROTEINS; PROTOZOAN VACCINES; TOXOPLASMA; TOXOPLASMOSIS, ANIMAL; VACCINES, DNA;

EID: 70350572316     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.08.043     Document Type: Article

References (29)

1. Jones J.L., Lopez A., Wilson M., Schulkin J., and Gibbs R. Congenital toxoplasmosis: a review. Obstet Gynecol Surv 56 5 (2001) 296-305
2. Cook G.C. Toxoplasma gondii infection: a potential danger to the unborn fetus and AIDS sufferer. Q J Med 74 273 (1990) 3-19
3. Dodds E.M. Toxoplasmosis. Curr Opin Ophthalmol 17 6 (2006) 557-561
4. Luft B.J., and Remington J.S. Toxoplasmic encephalitis in AIDS. Clin Infect Dis 15 2 (1992) 211-222
5. Machado C.M., Boas L.S., Canto C.L., Andrade Junior H.F., Castelli J., Bohringer P., et al. Disseminated toxoplasmosis after BMT-report of a case. Bone Marrow Transplant 10 5 (1992) 475-478
6. Israelski D.M., and Remington J.S. Toxoplasmosis in patients with cancer. Clin Infect Dis 17 Suppl. 2 (1993) 423-435
7. Dubey J.P., Hill D.E., Jones J.L., Hightower A.W., Kirkland E., Roberts J.M., et al. Prevalence of viable Toxoplasma gondii in beef, chicken, and pork from retail meat stores in the United States: risk assessment to consumers. J Parasitol 91 5 (2005) 1082-1093
8. Zou F.C., Sun X.T., Xie Y.J., Li B., Zhao G.H., Duan G., et al. Seroprevalence of Toxoplasma gondii in pigs in Southwestern China. Parasitol Int 58 3 (2009) 306-307
9. Buxton D. Protozoan infections (Toxoplasma gondii, Neospora caninum and Sarcocystis spp.) in sheep and goats: recent advances. Vet Res 29 3-4 (1998) 289-310
10. Bhopale G.M. Development of a vaccine for toxoplasmosis: current status. Microbes Infect 5 5 (2003) 457-462
11. Innes E.A., and Vermeulen A.N. Vaccination as a control strategy against the coccidial parasites Eimeria, Toxoplasma and Neospora. Parasitology 133 Suppl (2006) 145-168
12. Darcy F., Maes P., Gras-Masse H., Auriault C., Bossus M., Deslee D., et al. Protection of mice and nude rats against toxoplasmosis by a multiple antigenic peptide construction derived from Toxoplasma gondii P30 antigen. J Immunol 149 11 (1992) 3636-3641
13. Wang H., Liu Q., Liu K., Zhong W., Gao S., Jiang L., et al. Immune response induced by recombinant Mycobacterium bovis BCG expressing ROP2 gene of Toxoplasma gondii. Parasitol Int 56 4 (2007) 263-268
14. Mishima M., Xuan X., Yokoyama N., Igarashi I., Fujisaki K., Nagasawa H., et al. Recombinant feline herpesvirus type 1 expressing Toxoplasma gondii ROP2 antigen inducible protective immunity in cats. Parasitol Res 88 2 (2002) 144-149
15. Mateus-Pinilla N.E., Dubey J.P., Choromanski L., and Weigel R.M. A field trial of the effectiveness of a feline Toxoplasma gondii vaccine in reducing T. gondii exposure for swine. J Parasitol 85 5 (1999) 855-860
16. Alarcon J.B., Waine G.W., and McManus D.P. DNA vaccines: technology and application as anti-parasite and anti-microbial agents. Adv Parasitol 42 (1999) 343-410
17. Gaechter V., and Hehl A.B. Assembly and export of a Toxoplasma microneme complex in Giardia lamblia. Int J Parasitol 35 13 (2005) 1359-1368
18. Opitz C., and Soldati D. 'The glideosome': a dynamic complex powering gliding motion and host cell invasion by Toxoplasma gondii. Mol Microbiol 45 3 (2002) 597-604
19. Reiss M., Viebig N., Brecht S., Fourmaux M.N., Soete M., Di Cristina M., et al. Identification and characterization of an escorter for two secretory adhesins in Toxoplasma gondii. J Cell Biol 152 3 (2001) 563-578
20. Opitz C., Di Cristina M., Reiss M., Ruppert T., Crisanti A., and Soldati D. Intramembrane cleavage of microneme proteins at the surface of the apicomplexan parasite Toxoplasma gondii. EMBO J 21 7 (2002) 1577-1585
21. Bounous D.I., Campagnoli R.P., and Brown J. Comparison of MTT colorimetric assay and tritiated thymidine uptake for lymphocyte proliferation assays using chicken splenocytes. Avian Dis 36 4 (1992) 1022-1027
22. Liu Q., Gao S., Jiang L., Shang L., Men J., Wang Z., et al. A recombinant pseudorabies virus expressing TgSAG1 protects against challenge with the virulent Toxoplasma gondii RH strain and pseudorabies in BALB/c mice. Microbes Infect 10 12-13 (2008) 1355-1362
23. Soldati D., Dubremetz J.F., and Lebrun M. Microneme proteins: structural and functional requirements to promote adhesion and invasion by the apicomplexan parasite Toxoplasma gondii. Int J Parasitol 31 12 (2001) 1293-1302
24. Zheng B., He A., Gan M., Li Z., He H., and Zhan X. MIC6 associates with aldolase in host cell invasion by Toxoplasma gondii. Parasitol Res 105 2 (2009) 441-445
25. Jongert E., Melkebeek V., De Craeye S., Dewit J., Verhelst D., and Cox E. An enhanced GRA1-GRA7 cocktail DNA vaccine primes anti-Toxoplasma immune responses in pigs. Vaccine 26 8 (2008) 1025-1031
26. Chen H., Chen G., Zheng H., and Guo H. Induction of immune responses in mice by vaccination with liposome-entrapped DNA complexes encoding Toxoplasma gondii SAG1 and ROP1 genes. Chin Med J (Engl) 116 10 (2003) 1561-1566
27. Mevelec M.N., Bout D., Desolme B., Marchand H., Magne R., Bruneel O., et al. Evaluation of protective effect of DNA vaccination with genes encoding antigens GRA4 and SAG1 associated with GM-CSF plasmid, against acute, chronical and congenital toxoplasmosis in mice. Vaccine 23 36 (2005) 4489-4499
28. Di Cristina M., Del Porto P., Buffolano W., Beghetto E., Spadoni A., Guglietta S., et al. The Toxoplasma gondii bradyzoite antigens BAG1 and MAG1 induce early humoral and cell-mediated immune responses upon human infection. Microbes Infect 6 2 (2004) 164-171
29. Lourenço E.V., Bernardes E.S., Silva N.M., Mineo J.R., Panunto-Castelo A., and Roque-Barreira M.C. Immunization with MIC1 and MIC4 induces protective immunity against Toxoplasma gondii. Microbes Infect 8 5 (2006) 1244-1251